Surreptitious manipulation of the human host by Helicobacter pylori

Gut Microbes

Volumn 1, Issue 2, 2010, Pages 119-127

  Israel, Dawn A ^a   Peek Jr , Richard M ^a,b,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bacterial pathogenesis; Gastric cancer; Immune evasion; Inflammation; Virulence factors

Indexed keywords

BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; BIOMANIPULATION; HELICOBACTER PYLORI; HOST PATHOGEN INTERACTION; HUMAN; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; REVIEW;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

EID: 77954820246     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.1.2.11991     Document Type: Review

References (151)

1. Tsuda M, Karita M, Morshed MG, Okita K, Nakazawa T. A urease-negative mutant of Helicobacter pylori concon structed by allelic exchange mutagenesis lacks the abilabil ity to colonize the nude mouse stomach. Infect Immun 1994; 62:3586-9.
2. Eaton KA, Gilbert JV, Joyce EA, Wanken AE, Thevenot T, Baker P, et al. In vivo complementation of ureB restores the ability of Helicobacter pylori to colonize. Infect Immun 2002; 70:771-8.
3. Hansen LM, Solnick JV. Selection for urease activity during Helicobacter pylori infection of rhesus macaques (Macaca mulatta). Infect Immun 2001; 69:3519-22.
4. Takashima M, Furuta T, Hanai H, Sugimura H, Kaneko E. Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils. Gut 2001; 48:765-73.
5. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymorpolymor phisms associated with increased risk of gastric cancer. Nature 2000; 404:398-402.
6. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, et al. Increased risk of noncardia gastric cancer associated with proinflammaproinflamma tory cytokine gene polymorphisms. Gastroenterology 2003; 124:1193-201.
7. Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002; 94:1680-7.
8. Ando T, El-Omar EM, Goto Y, Nobata K, Watanabe O, Maeda O, et al. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disdis ease through induction of corpus atrophy. Gut 2006; 55:158-64.
9. Machado JC, Figueiredo C, Canedo P, Pharoah P, Carvalho R, Nabais S, et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003; 125:364-71.
10. Josenhans C, Labigne A, Suerbaum S. Comparative ultrastructural and functional studies of Helicobacter pylori and Helicobacter mustelae flagellin mutants: both flagellin subunits, FlaA and FlaB, are necessary for full motility in Helicobacter species. J Bacteriol 1995; 177:3010-20.
11. Eaton KA, Suerbaum S, Josenhans C, Krakowka S. Colonization of gnotobiotic piglets by Helicobacter pylori deficient in two flagellin genes. Infect Immun 1996; 64:2445-8.
12. Kavermann H, Burns BP, Angermuller K, Odenbreit S, Fischer W, Melchers K, et al. Identification and characterization of Helicobacter pylori genes essential for gastric colonization. J Exp Med 2003; 197:813-22.
13. Andersen-Nissen E, Smith KD, Strobe KL, Barrett SL, Cookson BT, Logan SM, et al. Evasion of Toll-like receptor 5 by flagellated bacteria. Proc Natl Acad Sci USA 2005; 102:9247-52.
14. Gewirtz AT, Yu Y, Krishna US, Israel DA, Lyons SL, Peek RM Jr. Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity. J Infect Dis 2004; 189:1914-20.
15. Guo BP, Mekalanos JJ. Rapid genetic analysis of Helicobacter pylori gastric mucosal colonization in sucksuck ling mice. Proc Natl Acad Sci USA 2002; 99:8354-9.
16. Ottemann KM, Lowenthal AC. Helicobacter pylori uses motility for initial colonization and to attain robust infection. Infect Immun 2002; 70:1984-90.
17. Cerda O, Rivas A, Toledo H. Helicobacter pylori strain ATCC700392 encodes a methyl-accepting chemotaxis receptor protein (MCP) for arginine and sodium bicarbicar bonate. FEMS Microbiol Lett 2003; 224:175-81.
18. Croxen MA, Sisson G, Melano R, Hoffman PS. The Helicobacter pylori chemotaxis receptor TlpB (HP0103) is required for pH taxis and for colonization of the gastric mucosa. J Bacteriol 2006; 188:2656-65.
19. McGee DJ, Langford ML, Watson EL, Carter JE, Chen YT, Ottemann KM. Colonization and inflaminflam mation deficiencies in Mongolian gerbils infected by Helicobacter pylori chemotaxis mutants. Infect Immun 2005; 73:1820-7.
20. Williams SM, Chen YT, Andermann TM, Carter JE, McGee DJ, Ottemann KM. Helicobacter pylori chemotchemot axis modulates inflammation and bacterium-gastric epithelium interactions in infected mice. Infect Immun 2007; 75:3747-57.
21. Terry K, Williams SM, Connolly L, Ottemann KM. Chemotaxis plays multiple roles during Helicobacter pylori animal infection. Infect Immun 2005; 73:803-11.
22. Hazell SL, Lee A, Brady L, Hennessy W. Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epitheepithe lium. J Infect Dis 1986; 153:658-63.
23. Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, Falkow S. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 2003; 300:1430-4.
24. Krueger S, Hundertmark T, Kuester D, Kalinski T, Peitz U, Roessner A. Helicobacter pylori alters the distridistri bution of ZO-1 and p120ctn in primary human gastric epithelial cells. Pathol Res Pract 2007; 203:433-44.
25. Wroblewski LE, Shen L, Ogden S, Romero-Gallo J, Lapierre LA, Israel DA, et al. Helicobacter pylori dysregulation of gastric epithelial tight junctions by urease-mediated myosin II activation. Gastroenterology 2009; 136:236-46.
26. Fedwick JP, Lapointe TK, Meddings JB, Sherman PM, Buret AG. Helicobacter pylori activates myosin lightlight chain kinase to disrupt claudin-4 and claudin-5 and increase epithelial permeability. Infect Immun 2005; 73:7844-52.
27. Liu Y, Nusrat A, Schnell FJ, Reaves TA, Walsh S, Pochet M, et al. Human junction adhesion molecule regulates tight junction resealing in epithelia. J Cell Sci 2000; 113:2363-74.
28. Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 1998; 141:1539-50.
29. Suzuki K, Kokai Y, Sawada N, Takakuwa R, Kuwahara K, Isogai E, et al. SS1 Helicobacter pylori disrupts the paracellular barrier of the gastric mucosa and leads to neutrophilic gastritis in mice. Virchows Arch 2002; 440:318-24.
30. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 1993; 123:1777-88.
31. Chen G, Sordillo EM, Ramey WG, Reidy J, Holt PR, Krajewski S, et al. Apoptosis in gastric epithelial cells is induced by Helicobacter pylori and accompanied by increased expression of BAK. Biochem Biophys Res Commun 1997; 239:626-32.
32. Balda MS, Whitney JA, Flores C, Gonzalez S, Cereijido M, Matter K. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane difdif fusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol 1996; 134:1031-49.
33. McCarthy KM, Skare IB, Stankewich MC, Furuse M, Tsukita S, Rogers RA, et al. Occludin is a funcfunc tional component of the tight junction. J Cell Sci 1996; 109:2287-98.
34. Wittchen ES, Haskins J, Stevenson BR. Protein interacinterac tions at the tight junction. Actin has multiple binding partners, and ZO-1 forms independent complexes with ZO-2 and ZO-3. J Biol Chem 1999; 274:35179-85.
35. Fanning AS, Jameson BJ, Jesaitis LA, Anderson JM. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem 1998; 273:29745-53.
36. Gerhard M, Lehn N, Neumayer N, Boren T, Rad R, Schepp W, et al. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci USA 1999; 96:12778-83.
37. Solnick JV, Hansen LM, Salama NR, Boonjakuakul JK, Syvanen M. Modification of Helicobacter pylori outer membrane protein expression during experimental infection of rhesus macaques. Proc Natl Acad Sci USA 2004; 101:2106-11.
38. Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, Incecik ET, et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998; 279:373-7.
39. Yamaoka Y, Kwon DH, Graham DY. A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci USA 2000; 97:7533-8.
40. Franco AT, Johnston E, Krishna U, Yamaoka Y, Israel DA, Nagy TA, et al. Regulation of gastric carcinogencarcinogen esis by Helicobacter pylori virulence factors. Cancer Res 2008; 68:379-87.
41. Mahdavi J, Sonden B, Hurtig M, Olfat FO, Forsberg L, Roche N, et al. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 2002; 297:573-8.
42. Imlay JA. Pathways of oxidative damage. Annu Rev Microbiol 2003; 57:395-418.
43. Seyler RW Jr, Olson JW, Maier RJ. Superoxide disdis mutase-deficient mutants of Helicobacter pylori are hypersensitive to oxidative stress and defective in host colonization. Infect Immun 2001; 69:4034-40.
44. Wang G, Olczak AA, Walton JP, Maier RJ. Contribution of the Helicobacter pylori thiol peroxidase bacterioferribacterioferri tin comigratory protein to oxidative stress resistance and host colonization. Infect Immun 2005; 73:378-84.
45. Olczak AA, Olson JW, Maier RJ. Oxidative-stress resisresis tance mutants of Helicobacter pylori. J Bacteriol 2002; 184:3186-93.
46. Olczak AA, Seyler RW Jr, Olson JW, Maier RJ. Association of Helicobacter pylori antioxidant activities with host colonization proficiency. Infect Immun 2003; 71:580-3.
47. Harris AG, Hinds FE, Beckhouse AG, Kolesnikow T, Hazell SL. Resistance to hydrogen peroxide in Helicobacter pylori: role of catalase (KatA) and Fur, and functional analysis of a novel gene product desdes ignated 'KatA-associated protein', KapA (HP0874). Microbiology 2002; 148:3813-25.
48. Harris AG, Wilson JE, Danon SJ, Dixon MF, Donegan K, Hazell SL. Catalase (KatA) and KatA-associated propro tein (KapA) are essential to persistent colonization in the Helicobacter pylori SS1 mouse model. Microbiology 2003; 149:665-72.
49. Wang G, Maier RJ. An NADPH quinone reductase of Helicobacter pylori plays an important role in oxidative stress resistance and host colonization. Infect Immun 2004; 72:1391-6.
50. Cooksley C, Jenks PJ, Green A, Cockayne A, Logan RP, Hardie KR. NapA protects Helicobacter pylori from oxioxi dative stress damage, and its production is influenced by the ferric uptake regulator. J Med Microbiol 2003; 52:461-9.
51. Wang G, Hong Y, Olczak A, Maier SE, Maier RJ. Dual Roles of Helicobacter pylori NapA in inducing and combating oxidative stress. Infect Immun 2006; 74:6839-46.
52. Olczak AA, Wang G, Maier RJ. Up-expression of NapA and other oxidative stress proteins is a compensatory response to loss of major Helicobacter pylori stress resisresis tance factors. Free Radic Res 2005; 39:1173-82.
53. Mendz GL, Hazell SL. The urea cycle of Helicobacter pylori. Microbiology 1996; 142:2959-67.
54. McGee DJ, Radcliff FJ, Mendz GL, Ferrero RL, Mobley HL. Helicobacter pylori rocF is required for arginase activity and acid protection in vitro but is not essential for colonization of mice or for urease activity. J Bacteriol 1999; 181:7314-22. www.landesbioscience.com
55. Gobert AP, McGee DJ, Akhtar M, Mendz GL, Newton JC, Cheng Y, et al. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc Natl Acad Sci USA 2001; 98:13844-9.
56. Chaturvedi R, Asim M, Lewis ND, Algood HM, Cover TL, Kim PY, et al. L-arginine availability reguregu lates inducible nitric oxide synthase-dependent host defense against Helicobacter pylori. Infect Immun 2007; 75:4305-15.
57. Perez-Perez GI, Shepherd VL, Morrow JD, Blaser MJ. Activation of human THP-1 cells and rat bone marrow-derived macrophages by Helicobacter pylori lipopolysaccharide. Infect Immun 1995; 63:1183-7.
58. Nielsen H, Birkholz S, Andersen LP, Moran AP. Neutrophil activation by Helicobacter pylori lipopolylipopoly saccharides. J Infect Dis 1994; 170:135-9.
59. Birkholz S, Knipp U, Opferkuch W. Stimulatory effects of Helicobacter pylori on human peripheral blood mononuclear cells of H. pylori infected patients and healthy blood donors. Int J Med Microbiol Virol Parasitol Infect Dis 1993; 280:166-76.
60. Taylor JM, Ziman ME, Fong J, Solnick JV, Vajdy M. Possible correlates of long-term protection against Helicobacter pylori following systemic or combinations of mucosal and systemic immunizations. Infect Immun 2007; 75:3462-9.
61. Wee JL, Chionh YT, Ng GZ, Harbour SN, Allison C, Pagel CN, et al. Protease-activated receptor-1 downregulates the murine inflammatory and humoral response to Helicobacter pylori. Gastroenterology 2010; 138:573-82.
62. Moran AP, Hynes SO, Heneghan MA. Mimicry of blood group antigen A by Helicobacter mustelae and H. pylori. Gastroenterology 1999; 116:504-5.
63. Monteiro MA, Appelmelk BJ, Rasko DA, Moran AP, Hynes SO, MacLean LL, et al. Lipopolysaccharide structures of Helicobacter pylori genomic strains 26695 and J99, mouse model H. pylori Sydney strain, H. pylori P466 carrying sialyl Lewis X, and H. pylori UA915 expressing Lewis B classification of H. pylori lipopolylipopoly saccharides into glycotype families. Eur J Biochem 2000; 267:305-20.
64. Monteiro MA, Chan KH, Rasko DA, Taylor DE, Zheng PY, Appelmelk BJ, et al. Simultaneous expresexpres sion of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides. Molecular mimicry between H. pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms. J Biol Chem 1998; 273:11533-43.
65. Monteiro MA, Rasko D, Taylor DE, Perry MB. Glucosylated N-acetyllactosamine O-antigen chain in the lipopolysaccharide from Helicobacter pylori strain UA861. Glycobiology 1998; 8:107-12.
66. Heneghan MA, McCarthy CF, Moran AP. Relationship of blood group determinants on Helicobacter pylori lipopolysaccharide with host lewis phenotype and inflammatory response. Infect Immun 2000; 68:937-41.
67. Simoons-Smit IM, Appelmelk BJ, Verboom T, Negrini R, Penner JL, Aspinall GO, et al. Typing of Helicobacter pylori with monoclonal antibodies against Lewis antianti gens in lipopolysaccharide. J Clin Microbiol 1996; 34:2196-200.
68. Wirth HP, Yang M, Peek RM Jr, Hook-Nikanne J, Fried M, Blaser MJ. Phenotypic diversity in Lewis expression of Helicobacter pylori isolates from the same host. J Lab Clin Med 1999; 133:488-500.
69. Appelmelk BJ, Martin SL, Monteiro MA, Clayton CA, McColm AA, Zheng P, et al. Phase variation in Helicobacter pylori lipopolysaccharide due to changes in the lengths of poly(C) tracts in alpha3-fucosyltransfucosyltrans ferase genes. Infect Immun 1999; 67:5361-6.
70. Appelmelk BJ, Shiberu B, Trinks C, Tapsi N, Zheng PY, Verboom T, et al. Phase variation in Helicobacter pylori lipopolysaccharide. Infect Immun 1998; 66:70-6.
71. Gibson JR, Chart H, Owen RJ. Intra-strain variation in expression of lipopolysaccharide by Helicobacter pylori. Lett Appl Microbiol 1998; 26:399-403.
72. Linden S, Boren T, Dubois A, Carlstedt I. Rhesus monkey gastric mucins: oligomeric structure, glycoglyco forms and Helicobacter pylori binding. Biochem J 2004; 379:765-75.
73. Wirth HP, Yang M, Sanabria-Valentin E, Berg DE, Dubois A, Blaser MJ. Host Lewis phenotype-dependepen dent Helicobacter pylori Lewis antigen expression in rhesus monkeys. Faseb J 2006; 20:1534-6.
74. Pohl MA, Romero-Gallo J, Guruge JL, Tse DB, Gordon JI, Blaser MJ. Host-dependent Lewis (Le) antigen expression in Helicobacter pylori cells recovered from Leb-transgenic mice. J Exp Med 2009; 206:3061-72.
75. Axsen WS, Styer CM, Solnick JV. Inhibition of heat shock protein expression by Helicobacter pylori. Microb Pathog 2009; 47:231-6.
76. Ozbek A, Ozbek E, Dursun H, Kalkan Y, Demirci T. Can Helicobacter pylori Invade Human Gastric Mucosa?: An In Vivo Study Using Electron Microscopy, Immunohistochemical Methods, and Real-time Polymerase Chain Reaction. J Clin Gastroenterol 2009; Epub ahead of print.
77. Amieva MR, Salama NR, Tompkins LS, Falkow S. Helicobacter pylori enter and survive within multivemultive sicular vacuoles of epithelial cells. Cell Microbiol 2002; 4:677-90.
78. Bjorkholm B, Zhukhovitsky V, Lofman C, Hulten K, Enroth H, Block M, et al. Helicobacter pylori entry into human gastric epithelial cells: A potential determidetermi nant of virulence, persistence, and treatment failures. Helicobacter 2000; 5:148-54.
79. Israel DA, Salama N, Arnold CN, Moss SF, Ando T, Wirth HP, et al. Helicobacter pylori strain-specific difdif ferences in genetic content, identified by microarray, influence host inflammatory responses. J Clin Invest 2001; 107:611-20.
80. Salama NR, Gonzalez-Valencia G, Deatherage B, Aviles-Jimenez F, Atherton JC, Graham DY, et al. Genetic analysis of Helicobacter pylori strain populapopula tions colonizing the stomach at different times postinpostin fection. J Bacteriol 2007; 189:3834-45.
81. Giannakis M, Backhed HK, Chen SL, Faith JJ, Wu M, Guruge JL, et al. Response of gastric epithelial progenitors to Helicobacter pylori isolates obtained from Swedish patients with chronic atrophic gastritis. J Biol Chem 2009; 284:30383-94.
82. Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and diseasedisease associated virulence factors. Proc Natl Acad Sci USA 1996; 93:14648-53.
83. Tummuru MK, Cover TL, Blaser MJ. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun 1993; 61:1799-809.
84. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993; 90:5791-5.
85. Torres J, Perez-Perez GI, Leal-Herrera Y, Munoz O. Infection with CagA+ Helicobacter pylori strains as a possible predictor of risk in the development of gastric adenocarcinoma in Mexico. Int J Cancer 1998; 78:298-300.
86. Queiroz DM, Mendes EN, Rocha GA, Oliveira AM, Oliveira CA, Magalhaes PP, et al. cagA-positive Helicobacter pylori and risk for developing gastric carcicarci noma in Brazil. Int J Cancer 1998; 78:135-9.
87. Rudi J, Kolb C, Maiwald M, Zuna I, von Herbay A, Galle PR, et al. Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma. Dig Dis Sci 1997; 42:1652-9.
88. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997; 40:297-301.
89. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55:2111-5.
90. Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995; 87:1777-80.
91. Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS, et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration and gastric pathology. Lancet 1991; 338:332-5.
92. Peek RM Jr, Miller GG, Tham KT, Perez-Perez GI, Zhao X, Atherton JC, et al. Heightened inflammainflamma tory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest 1995; 73:760-70.
93. Kwok T, Zabler D, Urman S, Rohde M, Hartig R, Wessler S, et al. Helicobacter exploits integrin for type IV secretion and kinase activation. Nature 2007; 449:862-6.
94. Jimenez-Soto LF, Kutter S, Sewald X, Ertl C, Weiss E, Kapp U, et al. Helicobacter pylori type IV secretion apparatus exploits beta1 integrin in a novel RGD- independent manner. PLoS Pathog 2009; 5:1000684.
95. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000; 287:1497-500.
96. Selbach M, Moese S, Hauck CR, Meyer TF, Backert S. Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J Biol Chem 2002; 277:6775-8.
97. Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002; 295:683-6.
98. Yamazaki S, Yamakawa A, Ito Y, Ohtani M, Higashi H, Hatakeyama M, et al. The CagA protein of Helicobacter pylori is translocated into epithelial cells and binds to SHP-2 in human gastric mucosa. J Infect Dis 2003; 187:334-7.
99. Azuma T, Yamakawa A, Yamazaki S, Fukuta K, Ohtani M, Ito Y, et al. Correlation between variation of the 3' region of the cagA gene in Helicobacter pylori and disease outcome in Japan. J Infect Dis 2002; 186:1621-30.
100. Stein M, Bagnoli F, Halenbeck R, Rappuoli R, Fantl WJ, Covacci A. c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol Microbiol 2002; 43:971-80.
101. Schneider N, Krishna U, Romero-Gallo J, Israel DA, Piazuelo MB, Camargo MC, et al. Role of Helicobacter pylori CagA molecular variations in induction of host phenotypes with carcinogenic potential. J Infect Dis 2009; 199:1218-21.
102. Argent RH, Kidd M, Owen RJ, Thomas RJ, Limb MC, Atherton JC. Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 2004; 127:514-23.
103. Argent RH, Thomas RJ, Aviles-Jimenez F, Letley DP, Limb MC, El-Omar EM, et al. Toxigenic Helicobacter pylori infection precedes gastric hypochlorhydria in cancer relatives, and H. pylori virulence evolves in these families. Clin Cancer Res 2008; 14:2227-35.
104. Rota CA, Pereira-Lima JC, Blaya C, Nardi NB. Consensus and variable region PCR analysis of Helicobacter pylori 3' region of cagA gene in isolates from individuals with or without peptic ulcer. J Clin Microbiol 2001; 39:606-12.
105. Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY. Relationship between Helicobacter pylori iceA, cagA and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol 1999; 37:2274-9.
106. Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, Azuma T, et al. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci USA 2002; 99:14428-33.
107. Bronte-Tinkew DM, Terebiznik M, Franco A, Ang M, Ahn D, Mimuro H, et al. Helicobacter pylori cytotoxincytotoxin associated gene A activates the signal transducer and activator of transcription 3 pathway in vitro and in vivo. Cancer Res 2009; 69:632-9.
108. Saadat I, Higashi H, Obuse C, Umeda M, Murataurata Kamiya N, Saito Y, et al. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 2007; 447:330-3.
109. Bagnoli F, Buti L, Tompkins L, Covacci A, Amieva MR. Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc Natl Acad Sci USA 2005; 102:16339-44.
110. Murata-Kamiya N, Kurashima Y, Teishikata Y, Yamahashi Y, Saito Y, Higashi H, et al. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transtrans differentiation in gastric epithelial cells. Oncogene 2007; 26:4617-26.
111. Zeaiter Z, Huynh HQ, Kanyo R, Stein M. CagA of Helicobacter pylori alters the expression and cellular distribution of host proteins involved in cell signaling. FEMS Microbiol Lett 2008; 288:227-34.
112. Lu H, Murata-Kamiya N, Saito Y, Hatakeyama M. Role of partitioning-defective 1/microtubule affinaffin ity regulating kinases in the morphogenetic activactiv ity of Helicobacter pylori CagA. J Biol Chem 2009; 284:23024-36.
113. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP, et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 2004; 5:1166-74.
114. Nagy TA, Frey MR, Yan F, Israel DA, Polk DB, Peek RM Jr. Helicobacter pylori regulates cellular migration and apoptosis by activation of phosphatidylinositol 3-kinase signaling. J Infect Dis 2009; 199:641-51.
115. Kaparakis M, Turnbull L, Carneiro L, Firth S, Coleman HA, Parkington HC, et al. Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells. Cell Microbiol 2009; 12:372-85.
116. Leunk RD, Johnson PT, David BC, Kraft WG, Morgan DR. Cytotoxic activity in broth-culture filfil trates of Campylobacter pylori. J Med Microbiol 1988; 26:93-9.
117. Lupetti P, Heuser JE, Manetti R, Massari P, Lanzavecchia S, Bellon PL, et al. Oligomeric and subunit structure of the Helicobacter pylori vacuolating cytotoxin. J Cell Biol 1996; 133:801-7.
118. Phadnis SH, Ilver D, Janzon L, Normark S, Westblom TU. Pathological significance and molecular characcharac terization of the vacuolating toxin gene of Helicobacter pylori. Infect Immun 1994; 62:1557-65.
119. Schmitt W, Haas R. Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: structural similarities with the IgA protease type of exported protein. Mol Microbiol 1994; 12:307-19.
120. Telford JL, Ghiara P, Dell'Orco M, Comanducci M, Burroni D, Bugnoli M, et al. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med 1994; 179:1653-58.
121. Cover TL, Tummuru MK, Cao P, Thompson SA, Blaser MJ. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem 1994; 269:10566-73.
122. Rhead JL, Letley DP, Mohammadi M, Hussein N, Mohagheghi MA, Eshagh Hosseini M, et al. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancan cer. Gastroenterology 2007; 133:926-36.
123. Letley DP, Lastovica A, Louw JA, Hawkey CJ, Atherton JC. Allelic diversity of the Helicobacter pylori vacuolatvacuolat ing cytotoxin gene in South Africa: rarity of the vacA s1a genotype and natural occurrence of an s2/m1 allele. J Clin Microbiol 1999; 37:1203-5.
124. Atherton JC, Cao P, Peek RM Jr, Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270:17771-7.
125. Czajkowsky DM, Iwamoto H, Cover TL, Shao Z. The vacuolating toxin from Helicobacter pylori forms hexahexa meric pores in lipid bilayers at low pH. Proc Natl Acad Sci USA 1999; 96:2001-6.
126. Cover TL, Blanke SR. Helicobacter pylori VacA, a parapara digm for toxin multifunctionality. Nat Rev Microbiol 2005; 3:320-32.
127. Iwamoto H, Czajkowsky DM, Cover TL, Szabo G, Shao Z. VacA from Helicobacter pylori: a hexameric chloride channel. FEBS Lett 1999; 450:101-4.
128. Tombola F, Carlesso C, Szabo I, de Bernard M, Reyrat JM, Telford JL, et al. Helicobacter pylori vacuolating toxin forms anion-selective channels in planar lipid bilayers: possible implications for the mechanism of cellular vacuolation. Biophys J 1999; 76:1401-9.
129. Szabo I, Brutsche S, Tombola F, Moschioni M, Satin B, Telford JL, et al. Formation of anion-selective chanchan nels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. EMBO J 1999; 18:5517-27.
130. Cover TL, Vaughn SG, Cao P, Blaser MJ. Potentiation of Helicobacter pylori vacuolating toxin activity by nicotine and other weak bases. J Infect Diseases 1992; 166:1073-8.
131. Li Y, Wandinger-Ness A, Goldenring JR, Cover TL. Clustering and redistribution of late endocytic comcom partments in response to Helicobacter pylori vacuolating toxin. Mol Biol Cell 2004; 15:1946-59.
132. Rieder G, Fischer W, Haas R. Interaction of Helicobacter pylori with host cells: function of secreted and translotranslo cated molecules. Curr Opin Microbiol 2005; 8:67-73.
133. Hotchin NA, Cover TL, Akhtar N. Cell vacuolation induced by the VacA cytotoxin of Helicobacter pylori is regulated by the Rac1 GTPase. J Biol Chem 2000; 275:14009-12.
134. Papini E, Satin B, Bucci C, de Bernard M, Telford JL, Manetti R, et al. The small GTP binding protein rab7 is essential for cellular vacuolation induced by Helicobacter pylori cytotoxin. EMBO J 1997; 16:15-24.
135. Papini E, de BM, Bugnoli M, Milia E, Rappuoli R, Montecucco C. Cell vacuolization induced by Helicobacter pylori: inhibition by bafilomycins A1, B1, C1 and D. FEMS Microbiology Letters 1993; 113:155-9.
136. Molinari M, Salio M, Galli C, Norais N, Rappuoli R, Lanzavecchia A, et al. Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA. J Exp Med 1998; 187:135-40.
137. Satin B, Norais N, Telford J, Rappuoli R, Murgia M, Montecucco C, et al. Effect of Helicobacter pylori vacuvacu olating toxin on maturation and extracellular release of procathepsin D and on epidermal growth factor degradation. J Biol Chem 1997; 272:25022-8.
138. Willhite DC, Cover TL, Blanke SR. Cellular vacuvacu olation and mitochondrial cytochrome c release are independent outcomes of Helicobacter pylori vacuvacu olating cytotoxin activity that are each dependent on membrane channel formation. J Biol Chem 2003; 278:48204-9.
139. Kimura M, Goto S, Wada A, Yahiro K, Niidome T, Hatakeyama T, et al. Vacuolating cytotoxin purified from Helicobacter pylori causes mitochondrial damage in human gastric cells. Microb Pathog 1999; 26:45-52.
140. Galmiche A, Rassow J, Doye A, Cagnol S, Chambard JC, Contamin S, et al. The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J 2000; 19:6361-70.
141. Yamasaki E, Wada A, Kumatori A, Nakagawa I, Funao J, Nakayama M, et al. Helicobacter pylori vacuolating cytotoxin induces activation of the proapoptotic propro teins Bax and Bak, leading to cytochrome c release and cell death, independent of vacuolation. J Biol Chem 2006; 281:11250-9.
142. Cover TL, Krishna US, Israel DA, Peek RM Jr. Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. Cancer Res 2003; 63:951-7.
143. Kuck D, Kolmerer B, Iking-Konert C, Krammer PH, Stremmel W, Rudi J. Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS. Infect Immun 2001; 69:5080-7.
144. Oldani A, Cormont M, Hofman V, Chiozzi V, Oregioni O, Canonici A, et al. Helicobacter pylori counteracts the apoptotic action of its VacA toxin by injecting the CagA protein into gastric epithelial cells. PLoS Pathog 2009; 5:1000603.
145. Mimuro H, Suzuki T, Nagai S, Rieder G, Suzuki M, Nagai T, et al. Helicobacter pylori dampens gut epithelial self-renewal by inhibiting apoptosis, a bacterial strategy to enhance colonization of the stomach. Cell Host Microbe 2007; 2:250-63.
146. Zheng PY, Jones NL. Helicobacter pylori strains expressexpress ing the vacuolating cytotoxin interrupt phagosome maturation in macrophages by recruiting and retaining TACO (coronin 1) protein. Cell Microbiol 2003; 5:25-40.
147. Allen LA, Schlesinger LS, Kang B. Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macmac rophages. J Exp Med 2000; 191:115-28.
148. Rittig MG, Shaw B, Letley DP, Thomas RJ, Argent RH, Atherton JC. Helicobacter pylori-induced homohomo typic phagosome fusion in human monocytes is indeinde pendent of the bacterial vacA and cag status. Cell Microbiol 2003; 5:887-99.
149. Boncristiano M, Paccani SR, Barone S, Ulivieri C, Patrussi L, Ilver D, et al. The Helicobacter pylori vacuvacu olating toxin inhibits T cell activation by two indepenindepen dent mechanisms. J Exp Med 2003; 198:1887-97.
150. Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 2003; 301:1099-102.
151. Sundrud MS, Torres VJ, Unutmaz D, Cover TL. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is indepenindepen dent of VacA effects on IL-2 secretion. Proc Natl Acad Sci USA 2004; 101:7727-32.